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Having two or more long-term conditions at the same time, known as 
multimorbidity, is a growing challenge globally. This workshop focused on 
finding out what is known about the extent and nature of multimorbidity 
and appropriate responses to it, where further research would be valuable 
and highlighted that addressing multimorbidity in a range of sub-Saharan 
countries will be heavily dependent on local contextual factors.
On 5–6 September 2019, researchers from across sub-Saharan Africa gathered in 
Sandton, Johannesburg, South Africa, to discuss the specific challenges in addressing 
multimorbidity in the region and the role that research could play. In particular, the 
ways research could improve understanding of multimorbidity in sub-Saharan Africa 
and identify the most effective ways to prevent and treat it. The meeting was jointly 
organised by the Academy of Medical Sciences, UK, and the Academy of Science of 
South Africa.
The meeting programme was developed by a steering committee chaired by 
Professor Alan Silman FMedSci, University of Oxford, UK, and Professor Karen 
Hofman MASSAf, University of the Witwatersrand, South Africa, and included 
researchers from multiple sub-Saharan African countries (Annex One).  This report 
provides a summary of the key themes to emerge from the meeting, as well as a set 
of high-level multimorbidity research priorities for the region. It reflects the views 
expressed by participants at the meeting and does not necessarily represent the 
views of all participants, all members of the steering committee, the Academy of 
Medical Sciences, or the Academy of Science of South Africa.
Executive summary
Multimorbidity is a growing challenge in sub-Saharan Africa with the 
growing adoption of westernised lifestyles driving a new non-communicable 
disease (NCD) epidemic. However, limited data are available on patterns of 
disease and its full burden across the region. Chronic infectious diseases, 
particularly HIV/AIDS, tuberculosis and hepatitis, typically make a greater 
contribution to multimorbidity in sub-Saharan Africa than in high-income 
countries (HICs), and they therefore tend to affect younger age groups.
Patterns of multimorbidity are also significantly affected by the dual burden of widespread childhood 
malnutrition – which has long-term impacts on cardiometabolic health – and rising levels of obesity and 
being overweight as populations are increasingly exposed to obesogenic environments. Increasing life 
expectancy and high population growth across the region are likely to have a major impact on the burden of 
multimorbidity in coming decades.
In addition, outcomes for people with multimorbidity are generally worse in sub-Saharan Africa than in 
HICs, reflecting deficiencies in timely diagnosis, access to treatment and management of conditions. 
The general public typically has low awareness of multimorbidity, and may erroneously consider chronic 
conditions to be inevitable consequences of ageing. Conceptions of mental health and mental illness may 
also be different from those in HICs.
An understanding of multimorbidity in sub-Saharan Africa is hampered by a lack of or limited data as 
well as variability in the types of populations and combinations of conditions studied. Importantly, due to 
genetic, physiologic or other factors, markers of health conditions may not translate directly from HICs to 
sub-Saharan African settings. 
All these factors illustrate the importance of generating sub-Saharan Africa-specific evidence – including 
data on regional patterns and trends in multimorbidity, drivers of multimorbidity, and effective prevention 
and treatment interventions and models of integrated health service delivery.
As well as low levels of research capacity in multimorbidity in sub-Saharan Africa, research is held back by 
organisational silos in clinical practice, research and also in funding, with some agencies restricting their 
support to specific individual diseases. These challenges are exacerbated by insufficient prioritisation of 
multimorbidity in sub-Saharan Africa and a lack of health system preparation, due to low political awareness 
of its importance and a lack of political commitment to address it.
During the meeting, participants identified a draft high-level sub-Saharan Africa-specific research agenda 
(see Box 1), within the framework of the global research priorities developed earlier in the Academy of 
Medical Sciences’ programme of work in multimorbidity. This agenda could provide a strategic framework to 
guide future research in the region.
Participants also identified cross-cutting factors that could act as research and translational enablers, 
accelerating multimorbidity research and its translation into practice more generally. These included:
•  Research capacity: Developing the knowledge, skills and infrastructure for multimorbidity research in 
the region.
•  Partnerships: Building ‘South–South’ and ‘South–North’ networks, including cross-disciplinary and 
cross-sectoral collaborations.
•  Adding value: Supplementing existing studies (e.g. cohorts, trials) to address multimorbidity- 
specific questions.
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•  Standardisation: Adopting a standard definition of multimorbidity and establishing sub-Saharan 
Africa-specific diagnostic cut-offs and standardised multimorbidity data sets.
•  Political engagement: Promoting early dialogue with ministries of health to encourage prioritisation 
of multimorbidity and involvement in projects.
• Community engagement: Developing stronger links with communities to promote multimorbidity 
health literacy, to understand attitudes and behaviours, and to engage communities in co-creation  
of interventions.
The outputs from this workshop will be taken forward by the participating academies in order to engage 
with policymakers in this area. This will help to address some of the priority areas highlighted during  
the workshop.
Box 1: Sub-Saharan Africa multimorbidity  
research priorities
Research priority 1: Trends and patterns
• Explore opportunities offered by existing cohorts/data sources to generate a clearer 
picture of local patterns of multimorbidity.
• Delineate multimorbidity patterns in different age groups (e.g. youth, older people).
•  Collate information on existing potential sources of multimorbidity data in a  
standardised form.
•  Scope new multimorbidity-specific cohorts/data sources.
Research priority 2: Clusters and burden
• Use simulations/modelling to estimate current and future burdens of multimorbidity.
• Develop novel approaches to determine the full societal/socioeconomic burden  
of multimorbidity.
Research priority 3: Determinants
• Characterise local/regional variation in established risk factors.
• Identify novel/locally important risk factors.
• Carry out region-specific causality assessments.
• Undertake root cause analyses/behavioural studies.
• Improve understanding of interactions between non-communicable and  
infectious diseases.
• Explore the impact of under- and over-nutrition and the life-course approach  
to multimorbidity.
• Analyse the role of the social/policy environment (e.g. food and drink regulation).
• Explore syndemic perspectives on multimorbidity.
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Research priority 4: Prevention
• Adapt and evaluate proven preventive interventions.
• Develop and evaluate novel context-specific interventions (including behaviour change 
communication interventions).
• Explore opportunities for ‘secondary’ prevention (e.g. after HIV diagnosis).
• Investigate multimorbidity health literacy and social attitudes to multimorbidity and  
its prevention.
• Develop and evaluate initiatives to promote good ‘brain health’.
• Inform the development of and evaluate ‘healthy cities’ initiatives.
• Promote multidisciplinary approaches, including collaborations with behavioural scientists 
and health economists.
Research priority 5: Treatment
• Develop and evaluate context-specific treatment interventions (including task- 
shifting interventions).
• Investigate the impact of polypharmacy, drug-drug interactions, adverse drug reactions.
• Adapt essential research tools from high-income countries (e.g. mental  
health assessments).
• Promote the use of pragmatic trials and greater use of real-world evidence.
Research priority 6: Healthcare systems
•  Promote implementation of evidence-based interventions.
•  Carry out cost-effectiveness studies to inform decision-making.
•  Evaluate models of integrated health and social care.
•  Explore potential for greater engagement with traditional healers and other community-
based providers.
•  Carry out equity analyses and evaluate innovative approaches for reaching vulnerable and 
neglected populations.
•  Identify effective approaches for policymaker engagement and dissemination of  
research findings.
• Promote greater use of implementation research.
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Introduction
As life expectancy increases, multimorbidity – the simultaneous presence of two or more 
chronic health conditions – is becoming increasingly common globally. The relationship 
between the conditions may be by chance, there may be particular risk factors that increase 
the risk of multiple diseases, or one condition (or its treatment) may predispose a person to 
another condition. Multimorbidity spans both physical and mental health conditions, this is 
important because a damaging reciprocal relationship can exist – chronic physical conditions 
can increase the risk of mental health conditions such as depression and mental health 
disorders can worsen physical symptoms or promote behaviours that harm physical health.
Notably, economic and social development has led to the widespread adoption of westernised lifestyles 
and a burgeoning of non-communicable diseases (NCDs) in sub-Saharan Africa – the NCD burden in the 
region increased by 67% between 1990 and 2017.1 Moreover, with a high infectious disease burden, 
greater life expectancy, and a population boom, multimorbidity threatens to be a huge issue for the 
region in the future.
Multimorbidity represents a challenge to health systems and to research, both of which are typically 
oriented around individual conditions. Patients may end up seeking care from a range of specialists, and 
care is not necessarily coordinated or delivered in a patient-centred way.
In 2016, the Academy of Medical Sciences established a working group, led by Professor Stephen 
MacMahon FMedSci, to develop a clearer global picture of multimorbidity and a research agenda to 
address it. The working group published a highly influential report in 2018,2 which included six strategic 
research priorities (Box 2).
The Academy of Medical Sciences’ programme of work in multimorbidity has included further workshops 
exploring more detailed questions, including multimorbidity in BRICS countries (Brazil, Russia, India, China 
and South Africa). A workshop held in September 2019, jointly organised by the Academy of Medical 
Sciences and the Academy of Science of South Africa, provided an opportunity to discuss the specific 
multimorbidity issues facing sub-Saharan Africa.
The main objectives of the workshop were to review the evidence on the prevention and management of 
multimorbidity in sub-Saharan Africa, to identify key gaps in knowledge and how they might be filled, and 
to discuss research initiatives successfully addressing prevention and management.
In breakout groups and plenary sessions, participants discussed key features of multimorbidity in sub-
Saharan Africa and identified a range of multimorbidity research priorities for the region, as well as 
enablers that could advance multimorbidity research more generally.
1. Gouda HN, Charlson F, Sorsdahl K, Ahmadzada S, Ferrari AJ, Erskine H, Leung J, Santamauro D, Lund C, Aminde LN, Mayosi BM, Kengne AP,  
 Harris M, Achoki T, Wiysonge CS, Stein DJ, Whiteford H (2019). Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results  
 from the Global Burden of Disease Study 2017. Lancet Glob Health 7(10):e1375-e1387.
2. Academy of Medical Sciences (2018). Multimorbidity: A priority for global health research.  
 https://acmedsci.ac.uk/policy/policyprojects/multimorbidity
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Box 2: Global multimorbidity research priorities1
Research priority 1: 
What are the trends and patterns in multimorbidity?
Research priority 2: 
Which multimorbidity clusters cause the greatest burden?
Research priority 3: 
What are the determinants of the most common clusters of conditions?
Research priority 4: 
What strategies are best able to facilitate the simultaneous or stepwise prevention of chronic 
conditions that contribute to the most common multimorbidity clusters?
Research priority 5: 
What strategies are best able to maximise the benefits and limit the risks of treatment among 
patients with multimorbidity?
Research priority 6: 
How can healthcare systems be better organised to maximise the benefits and limit the risks 
for patients with multimorbidity?
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3. Lelijveld N, Seal A, Wells JC, Kirkby J, Opondo C, Chimwezi E, Bunn J, Bandsma R, Heyderman RS, Nyirenda MJ, Kerac M (2016). Chronic disease 
 outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study. Lancet Glob Health 4(9):e654–62.
4. World Health Organization (WHO) (2016). Obesity and overweight. Geneva: WHO. 
5. United Nations. Population. New York: United Nations. Available at www.un.org/en/sections/issues-depth/population/index.html.
6. Chang AY, Gómez-Olivé FX, Payne C, Rohr JK, Manne-Goehler J, Wade AN, Wagner RG, Montana L, Tollman S, Salomon JA (2019). Chronic 
 multimorbidity among older adults in rural South Africa. BMJ Glob Health 4(4):e001386.
7. Woldesemayat EM, Kassa A, Gari T, Dangisso MH (2018). Chronic diseases multi-morbidity among adult patients at Hawassa University 
 Comprehensive Specialized Hospital. BMC Public Health 18(1):352.
8. Hien H, Berthé A, Drabo MK, Meda N, Konaté B, Tou F, Badini-Kinda F, Macq J (2014). Prevalence and patterns of multimorbidity among the 
 elderly in Burkina Faso: cross-sectional study. Trop Med Int Health 19(11):1328–33.
9. Kabakambira JD, Baker RL Jr, Briker SM, Courville AB, Mabundo LS, DuBose CW, Chung ST, Eckel RH, Sumner AE (2018). Do current guidelines  
 for waist circumference apply to black Africans? Prediction of insulin resistance by waist circumference among Africans living in America. BMJ  
 Glob Health 3(5):e001057.
Patterns of morbidity in sub-Saharan Africa show several distinct features, which influence the nature of 
multimorbidity in the region. For example, chronic infections, including HIV, tuberculosis (TB) and hepatitis, 
are common, and multimorbidity therefore tends to affect proportionately more younger people than in 
HICs (even after allowing for the younger age structure). Chronic infections can increase the risk or severity 
of other health conditions, while long-term treatment can also adversely affect aspects of health.
In addition, life expectancy is on the rise in sub-Saharan Africa. Growing numbers of older people, 
urbanisation, as well as the widespread adoption of westernised lifestyles are significantly increasing the 
burden of non-communicable diseases (NCDs) in the region. Sub-Saharan Africa now faces the dual, 
somewhat paradoxical challenges of widespread food insecurity and malnutrition – which can have major 
long-term consequences for the development and health of children3 – as well as growing rates of obesity4 
linked to economic development. Demographic changes, particularly high rates of population growth,5 raise 
the prospect of substantial increases in the multimorbidity burden in coming decades.
However, the full impact of NCDs and multimorbidity in the region is hard to judge. High-quality data are 
available from a limited number of cohorts in the region, but may not be generalisable. Data from national 
demographic and health surveys are not yet widely used to provide information on local patterns or trends 
in multimorbidity. As a result, much of the data on NCDs and multimorbidity come from a relatively limited 
number of countries, particularly South Africa.
Nevertheless, available data suggest that multimorbidity is a major issue. Data from the Agincourt cohort in 
South Africa, for example, reveal that 69.4% of people aged 40 years and above have at least two health 
conditions.6 A cross-sectional study of hospital attendees aged 18 and above in Ethiopia found that 18% 
had more than one chronic health condition,7 while a community-based cross-sectional study in Burkina 
Faso found multimorbidity rates of 65% in people aged 60 and above.8
Furthermore, patients with multimorbidity typically experience significantly worse outcomes in sub-
Saharan Africa than in HICs. This reflects a combination of factors, including late diagnosis, limited access to 
treatment, and poor long-term management of conditions.
These studies also highlight one of the challenges of multimorbidity research – the use of multiple different 
methods of characterising multimorbidity. Furthermore, there is not necessarily an agreement on the most 
appropriate diagnostic criteria for certain conditions. In particular, for genetics related reasons, the cut-offs 
used in HICs to define a disorder or condition may not be appropriate for sub-Saharan African populations. 
For example, waist circumference predictive of insulin resistance is different for people of European and 
African heritage.9
Multimorbidity in sub-Saharan Africa
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In general, healthcare systems in sub-Saharan Africa are poorly prepared to manage multimorbidity. 
Many countries have limited health system infrastructure and face chronic shortages of trained healthcare 
personnel. New healthcare delivery mechanisms have been developed, particularly for HIV, but these often 
focus only on single conditions and may not be fully integrated into wider health systems. Mental health 
has also been a relatively neglected aspect of health, although there are signs that this may be beginning to 
change and its importance to multimorbidity is being recognised.10
In addition, community awareness of multimorbidity is generally low and chronic conditions such as 
hypertension and high blood glucose are poorly controlled. Prevention may be being held back by fatalistic 
attitudes and the perception that health conditions and loss of function are a natural consequence of 
ageing, rather than deficits that can be delayed or avoided altogether. Perceptions of mental health 
disorders such as depression also vary according to local culture, and detection of mental health conditions is 
challenging without culturally sensitive instruments.
These factors emphasise the fundamental importance of sub-Saharan Africa-specific evidence. A 
deeper understanding of local causes and drivers of multimorbidity could be used to underpin the design 
of tailored preventive strategies. A clearer picture of local patterns and trends in multimorbidity would 
support prioritisation of efforts. Region-specific evidence is also required for locally applicable approaches to 
prevention, treatment and health system organisation.
However, silo working creates important organisational barriers. Specialist clinical practice is still mostly 
discipline-specific, with few examples of integrated patient-centric care. Departmental divisions in research 
are obstacles to the multidisciplinary approaches that multimorbidity demands. Funding agencies may also 
specify narrowly focused research, or bring their own research agendas that do not necessarily align with 
national priorities.
These challenges are exacerbated by insufficient prioritisation of multimorbidity in sub-Saharan Africa. 
This spans generally poor health system preparedness for multimorbidity, as well as low political awareness 
of the importance of multimorbidity and insufficient political commitment to address it.
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10. Stein DJ, Benjet C, Gureje O, Lund C, Scott KM, Poznyak V, van Ommeren M (2019). Integrating mental health with other non-communicable 
 diseases. BMJ 364:l295.
Research priority 1: Trends and patterns
Explore opportunities offered by existing cohorts/data sources to generate a clearer picture of 
local patterns of multimorbidity.
Some cohorts have been established for research purposes across sub-Saharan Africa. Although they are 
unlikely to be fully representative of populations, they provide an opportunity to gather high-quality data 
on multimorbidity in African settings. However, they are restricted to a limited number of countries and 
may not necessarily be large enough to provide a detailed picture of multimorbidity. 
National health and demographic surveys may also hold valuable data on multimorbidity and allow trends 
over time to be determined. Electronic health records represent another potential source of information, 
but these are not yet widely used in the region. Individual countries may also have sources of data, such 
as enrollees in health insurance schemes, which could shed light on aspects of multimorbidity, although 
such sources are again not likely to be representative of general populations. In contrast to HICs, there 
are no national or even regional routine health data capture systems and there is no alternative but to 
establish cohorts for the research.
Delineate multimorbidity patterns in different age groups (e.g. youth, older people).
The nature of multimorbidity is likely to differ significantly between different age groups. Existing data 
sources could provide opportunities to shed light on disease burdens at different ages, for example 
established research cohorts.
Collate information on existing potential sources of multimorbidity data in a  
standardised form.
Research efforts would benefit from a regional directory describing potential sources of multimorbidity 
data. A template should be developed to ensure coordinated and systematised descriptions of data 
sources. These efforts should also draw on existing data-source directories.
Scope new multimorbidity-specific cohorts/data sources.
Cohorts set up specifically to document the full spectrum of morbidities, and potential risk factors, would 
provide the most relevant data on multimorbidity and its evolution over time. By revealing more about 
the order in which morbidities develop, longitudinal studies could also shed light on chains of causality. 
However, creating new cohorts is costly and long-term sustainability is a major challenge. Initial research 
efforts could focus on the feasibility of establishing new cohorts, or of using routinely collected data, and 
identifying the key research questions that they would answer.
Research priority 2: Clusters and burden
Use simulations/modelling to estimate current and future burdens of multimorbidity.
In the absence of extensive data, simulations and modelling could be used to provide estimates of the 
impact of multimorbidity, and how this is likely to change in the future given demographic, developmental 
and disease trends. Such analyses could inform national decision-making on allocation of resources and 
organisation of health services.
Develop novel approaches to determine the full societal/socioeconomic burden of 
multimorbidity.
The impact of multimorbidity on individuals, households and socioeconomic development is poorly 
understood. More work is needed to identify the critical functional impacts of multimorbidity, and how 
these translate into social and economic impacts at the household and wider levels. Such data would 
provide a more accurate picture of the burden of multimorbidity and the benefits of prevention.
Meeting the multimorbidity challenge in 
sub-Saharan Africa: Research priorities
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Research priority 3: Determinants
Characterise local/regional variation in established risk factors.
Many lifestyle and other risk factors for chronic conditions are well-established. However, it is less clear 
whether any of them increase the risk of multimorbidity, above and beyond their impact on individual 
conditions. Data on the prevalence of risk factors in local populations, and their relative importance to 
multimorbidity, could be used to inform and prioritise preventive interventions.
Identify novel/locally important risk factors.
Populations in sub-Saharan Africa may be exposed to environmental or other risk factors that are rare or 
absent in HICs (such as smoke from cook stoves, civil conflict, and rheumatic heart disease). Exploratory 
research could be used to identify these risk factors and their potential contribution to local  
disease burden.
Carry out region-specific causality assessments.
More extensive longitudinal data on local patterns of disease could support analyses of the order in 
which conditions develop and the impacts they have on each other, which may not necessarily mirror 
that seen in HICs. Such analyses could reveal common risk factors and underpin more targeted preventive 
interventions.
Undertake root cause analyses/behavioural studies.
Social and behavioural studies could explore the pathways through which distal risk factors (such as 
socioeconomic status) influence proximal social and behavioural risk factors and ultimately health. Such 
studies could shed light on the attitudes and beliefs that drive lifestyle behaviours which increase the risk 
of multimorbidity, to underpin targeted behavioural or other interventions.
Improve understanding of interactions between non-communicable and infectious diseases.
Despite much progress having been made, infectious diseases remain prevalent in sub-Saharan Africa. As 
well as major killers such as HIV/AIDS, TB and malaria, neglected infectious diseases account for a huge 
burden of disease. There is a need to develop a better understanding of the two-way interactions between 
infectious and non-infectious causes of disease – how infections increase the risk of NCDs or exacerbate 
their impact and vice versa. Such understanding could help to improve patient care to reduce the risk of 
further morbidities or their impact.
Explore the impact of under- and over-nutrition and the life-course approach to multimorbidity.
Sub-Saharan Africa faces the dual challenge of persistent food insecurity and rising levels of being 
overweight and obesity – often, with a rapid transition between the two. Research is needed on the 
contributions of each to multimorbidity, and in particular on the long-term consequences of early-life 
nutritional adversity and maternal under-nutrition. 
The life-course perspective could also shed light on the long-term consequences of exposure to risk factors 
during key stages of life such as adolescence and early adulthood.
Analyse the role of the social/policy environment (e.g. food and drink regulation).
A specific strand of research could focus on the impact of social policies in either increasing or reducing 
risk exposures and behaviours, and generate evidence to inform policymaking. Research could explore 
the extent to which permissive policies may create environments that promote unhealthy behaviours. 
Conversely, countries and local governments have introduced policies that aim to reduce consumption of 
tobacco, alcohol and unhealthy foodstuffs, and promote healthy lifestyle choices. Evidence of the impact 
of such initiatives, at national or local levels, could support their wider introduction.
Explore syndemic perspectives on multimorbidity.
The syndemic approach11,12 emphasises the importance of considering holistically the biological, social and 
environmental factors that contribute to multiple overlapping epidemics or clusters of disease and disease 
inequities. Framing of multimorbidity in this context could help to identify common interests across sectors 
and galvanise action across multiple domains, with wide-ranging benefits on health and wellbeing.
11. Willen SS, Knipper M, Abadía-Barrero CE, Davidovitch N (2017). Syndemic vulnerability and the right to health. Lancet 389(10072):964–977.
12. Mendenhall E, Kohrt BA, Norris SA, Ndetei D, Prabhakaran D (2017). Non-communicable disease syndemics: poverty, depression, and diabetes 
 among low-income populations. Lancet 389(10072):951–963.
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WoW! WesternCape on Wellness
The WoW! programme is designed to enable people to make healthy lifestyle 
choices across the life course.
Developed by Western Cape Government and partners, including academic groups, 
WoW! is an evidence-based, cross-sectoral, comprehensive community-based programme 
addressing key risk factors for multimorbidity, including diet, inactivity, social isolation 
and risk behaviours, and spans both individual and social determinants of wellness. It 
incorporates a continuous improvement framework so that lessons learned can be applied 
for immediate corrective actions. 
An evaluation of the WoW! Phase-1 pilot programme in 2015–17 found that at baseline, 
more than 80% of participants were overweight or obese, more than 50% had high blood 
pressure, and less than 25% were meeting physical activity recommendations. Barriers to 
lifestyle change included a lack of knowledge and resources, lack of time, and an inability to 
prioritise lifestyle change. 
The programme achieved marked improvements in blood pressure at 3 months, and 
improvements in self-reported healthy eating, physical activity, quality of life and general 
health status, and significant reductions in waist circumference and in sedentary time at  
6 months.
www.westerncape.gov.za/westerncape-on-wellness/
Research priority 4: Prevention
Adapt and evaluate proven preventive interventions.
Multiple preventive interventions have been shown to be effective in reducing the risk of NCDs. However, 
these may not necessarily be appropriate for particular social contexts, or may not fulfill cost-effectiveness 
criteria. Research is required to adapt evidence-based interventions and to confirm the efficacy of locally 
tailored versions that could be scaled within local systems.
Develop and evaluate novel context-specific interventions (including behaviour change
communication interventions).
Research into local determinants of multimorbidity could underpin the development and evaluation 
of novel interventions targeted at locally important risk factors. These could include behaviour change 
communication/communication for development (C4D) interventions created locally but rooted in a strong 
theoretical framework.
Explore opportunities for ‘secondary’ prevention (e.g. after HIV diagnosis).
The diagnosis of a health condition provides an initial contact point with a health system, while the 
management of chronic conditions is likely to trigger multiple further contacts. These provide opportunities 
to integrate additional assessments and preventive interventions, focused on the most common  
co-morbidities.
Investigate multimorbidity health literacy and social attitudes to multimorbidity and its 
prevention.
Public understanding of multimorbidity and associated risk factors is generally low, and fatalistic attitudes 
may be an obstacle to the adoption of healthier lifestyles. The design of effective preventive interventions 
will require a deeper understanding of individual attitudes and social norms, as well as of key enablers of 
(and barriers to) healthier behaviours.
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Develop and evaluate initiatives to promote good ‘brain health’.
The importance of good mental health is increasingly recognised; building resilience to adversity and 
because of its protective effect on physical health. In addition, protection against cognitive decline with 
age will become more important as life expectancy continues to increase. More research is needed on the 
key attributes of a ‘healthy brain’, and on how good brain health can be promoted in sub-Saharan  
African contexts.
Inform the development of and evaluate ‘healthy cities’ initiatives.
The world is rapidly urbanising – 68% of the world’s population is likely to be living in cities by 2050, with 
the urban population of Africa projected to almost triple.13 Rapid urbanisation presents major challenges, 
driving behavioural changes that increase the risk of NCDs and adding further strain on under-developed 
health systems. Additional research is needed on how cities can prepare for population growth while 
promoting good health and wellbeing.
Promote multidisciplinary approaches, including collaborations with behavioural scientists and
health economists.
Effective prevention of multimorbidity calls for a multifaceted approach to understand the full range of 
biological, social, behavioural, environmental and structural drivers of ill-health. The design and evaluation 
of preventive interventions requires a similarly pluralistic approach. Evaluations should also include health 
economic analyses in order to inform policymaking and ensure cost-effective use of limited resources.
Research priority 5: Treatment
Develop and evaluate context-specific treatment interventions (including task-shifting
interventions).
Multiple proven interventions are available to treat both individual infectious diseases and NCDs. A major 
challenge is to adapt those most appropriate for low-resource settings, and to design interventions 
to address multimorbidity which fit local healthcare and cultural contexts. Given healthcare worker 
shortages, there is great potential to develop and evaluate task-shifting interventions to improve access  
to care.
Investigate the impact of polypharmacy, drug-drug interactions, adverse drug reactions.
Multimorbidity, including widespread co-existence of infectious diseases and NCDs, leads to frequent use 
of multiple drug treatments (polypharmacy). Some medications are known to interfere with each other’s 
actions, but there are few data on how they interact, particularly in sub-Saharan African populations. 
In addition, while the long-term survival of people living with HIV who are taking antiretroviral drugs 
(ARVs) has been a positive outcome, the extended periods on ARVs are creating new challenges, due to 
the long-term effects of both HIV infection and HIV medication.
Promote the use of pragmatic trials and greater use of real-world evidence.
Clinical trials typically focus on single conditions, and their clinical settings may not be typical of routinely 
used health facilities. Given the diversity of multimorbidity, it is challenging to gather evidence through 
such approaches. Pragmatic trials, run in situations as close as possible to routine care, have the potential 
to generate evidence more directly relevant to the treatment of multimorbidity. In addition, data captured 
in routine care, for example in electronic health records, could also hold important information on the 
effectiveness of treatments and the risks of adverse events.
13. United Nations Department of Economic and Social Affairs (2019). World Urbanisation Prospects 2018. New York: United Nations. Available at: 
 https://www.un.org/en/development/desa/population/theme/urbanization/index.asp.
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14. Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM (2015). An introduction to implementation science for the non-specialist. BMC  
 Psychol 3:32.
Research priority 6: Healthcare systems
Promote implementation of evidence-based interventions.
Evidence has been accumulating on effective interventions for NCDs, including mental health, albeit not 
necessarily in the context of multimorbidity. However, their implementation in practice is emerging as a 
key translational bottleneck. The reasons may be manifold, from lack of a policy framework promoting 
uptake through to practical challenges in the uptake of new ways of working.
Carry out cost-effectiveness studies to inform decision-making.
Financial resources for healthcare are inevitably limited. Health economic analyses can provide quantitative 
data on the financial impacts of implementing new interventions and ways of working to inform decision-
making. Ideally, cost-effectiveness studies should also incorporate the wider social and economic benefits 
of more effective prevention and the management of multimorbidity, as well as the costs of inaction.
Carry out equity analyses and evaluate innovative approaches for reaching vulnerable and
neglected populations.
Health economic analyses provide a rigorous and rational approach for determining the most cost-
effective use of health resources. However, in a world of limited resources, utilitarian calculations can 
disadvantage hard-to-reach or vulnerable populations – who may be at high risk but require targeted 
strategies. An equity lens can ensure that the needs of such populations are considered in health 
policymaking.
Evaluate models of integrated health and social care.
The distinction between health and social care is often artificial, and both domains are likely to be critical 
to effective prevention and management of multimorbidity. In particular, communities will have a vital role 
to play in supporting individuals and promoting pro-health social norms. Research is needed to develop 
and evaluate integrated models of health and social care that fit local contexts.
Explore potential for greater engagement with traditional healers and other community-based
providers.
In many countries, traditional healers or other informal practitioners are often the first to be consulted by 
people with health problems. Given their respected status in certain communities, some efforts have been 
made to engage with the informal health sector, to promote more evidence-based practices and improve 
linkage to formal healthcare systems. More evidence is needed on how best to build relationships and the 
effectiveness of such approaches in improving the prevention and management of multimorbidity.
Identify effective approaches for policymaker engagement and dissemination of research 
findings.
The principal route for the dissemination of research findings is through academic papers. However, 
policymakers generally do not have sufficient time or expertise to assimilate the research literature, and 
researchers may not be skilled in presenting findings in ways that are useful to policymakers. More work 
is needed to identify the most effective approaches for strengthening the relationship between evidence-
providers and evidence-users.
Promote greater use of implementation research.
Implementation science14 is a relatively new area of research focusing on factors impeding or facilitating 
the introduction of evidence-based innovations into health systems. A body of evidence is building on 
the most effective ways to plan implementation and to evaluate implementation activities to ensure more 
successful rollout of new interventions and working practices. A greater focus on implementation research 
will ensure that proven interventions are delivered effectively to patients and that they improve the 
performance of health systems.
Research and translational enablers.
Participants also identified a range of factors that could function as research and translational 
enablers, accelerating multimorbidity research and its uptake into practice.
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Research capacity.
Sub-Saharan Africa currently has limited capacity to carry out multimorbidity research, including not 
having sufficient appropriately trained researchers. In part, this reflects more general underdeveloped 
research capacity in the region, but a tendency towards specialisation in research is also a significant 
barrier. Efforts are needed to strengthen capacity for multimorbidity research – including the development 
of people as well as health systems able to host research studies – as part of wider efforts to build 
research capacity in the region.
Partnerships.
There is potential to build multimorbidity-focused ‘communities of practice’, through greater ‘South-
South’ and ‘South-North’ networking. Such partnerships could provide a framework for sharing of 
information and experience, and underpin international multicentre research collaborations. Ideally, such 
partnerships need to be broad in scope, including cross-disciplinary and cross-sectoral collaborations. 
Platforms such as that managed by the Global Health Network (https://tghn.org) could support greater 
sharing of knowledge and capacity development.
PACK: The Practical Approach to Care Kit
The PACK guide provides primary care health workers with practical guidance on 
detection and management of multiple long-term conditions.
Primary healthcare facilities in low-resource settings are typically understaffed, have a high 
workload and rely on workers with minimal levels of training. Increasingly, staff are caring 
for patients with multiple conditions, yet their training and clinical guidelines are typically 
oriented around individual conditions.
Developed by the University of Cape Town Knowledge Translation Unit, the PACK guide 
is an integrated and practical tool for primary healthcare workers to refer to during 
consultations. It draws evidence from multiple sources for multiple conditions, filtered 
according to the needs and constraints of low-income settings.
PACK has been evaluated in four pragmatic randomised controlled trials collectively 
spanning 33,000 patients and 124 clinics. It has been shown to improve clinical outcomes, 
enhance utilisation of healthcare resources, and boost care worker morale. PACK has been 
introduced into primary care facilities across South Africa, and it has been adapted for use in 
Botswana, Nigeria, Ethiopia and Brazil. Its use in other countries is being explored.15
https://pack.bmj.com
15. Simelane ML, Georgeu-Pepper D, Ras CJ, Anderson L, Pascoe M, Faris G, Fairall L, Cornick R (2018). The Practical Approach to Care Kit (PACK) 
 training programme: scaling up and sustaining support for health workers to improve primary care. BMJ Glob Health 3(Suppl 5):e001124.
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Cross-cutting themes
Project MIND
Project MIND is an experimental study comparing two possible ways of 
integrating mental healthcare into treatment programmes for chronic NCDs.
People with chronic NCDs are at an increased risk of mental health disorders. In addition, 
there is a reciprocally harmful relationship between the two – mental health issues 
exacerbate the severity of chronic NCDs and vice versa.
Project MIND is a collaborative research study between the South African Medical Research 
Council, the University of Cape Town, the University of Oxford, and the Western Cape 
Department of Health. It is being run as a three-arm randomised controlled trial comparing 
usual treatment and two forms of counselling – a ‘dedicated’ model where counselling is 
provided in groups by outside specialists and a ‘designated’ model in which a participant is 
trained to deliver the intervention.
As well as the impacts on NCDs and mental health outcomes, the project will also 
assess the cost-effectiveness of the two models and explore implications for wider 
implementation.
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Adding value.
Creating new infrastructure to manage multimorbidity or to carry out multimorbidity research is highly 
challenging. A more practical approach is to consider how additional services can be integrated into 
existing systems. Examples include initiatives focusing on the mental health of people receiving treatment 
for HIV or diabetes. The Practical Approach to Care Kit (PACK) goes a step further, supporting integrated 
primary healthcare for multiple chronic conditions (see PACK project box).
Similarly, for research, building on existing research infrastructure could be a cost-effective way to 
generate new knowledge. Data collection relevant to multimorbidity could be integrated into existing 
cohort programmes. In addition, multimorbidity-related questions could be addressed by extending or 
following up participants in existing clinical trials.
Standardisation.
To a degree, multimorbidity research is held back by the lack of an agreed definition of multimorbidity 
and common tools for assessing it. Adopting a single definition of multimorbidity, such as that proposed 
by the Academy of Medical Sciences working group,1 could provide a firm foundation for future research.
Disease definitions and diagnoses are often based on data from populations of European heritage, which 
are not necessarily directly transferable to sub-Saharan Africa. There is a need to establish sub-Saharan 
Africa-specific cut-offs to support more regionally appropriate diagnoses for key conditions such as 
hypertension and insulin resistance/diabetes. Context-sensitive mental health screening tools are also 
required. As well as translation into local languages, terminology used to describe mental distress or other 
key aspects of mental health may need to be adapted to suit local contexts. Research is needed to ensure 
that adapted tools retain their validity and enable meaningful comparisons to be made across populations.
Political engagement. 
Multimorbidity research is also partially being held back by limited political awareness of its importance 
and a lack of political commitment. Greater advocacy for multimorbidity may be required, with 
multimorbidity researchers potentially acting as national and regional ‘multimorbidity champions’. More 
evidence of the current and likely future impact of multimorbidity, including the cost of inaction, could 
also help to build political commitment.
The development of national plans for universal health coverage could provide an opportunity to 
strengthen both political commitment and health system preparedness for multimorbidity. Stressing its 
relevance to the attainment of Sustainable Development Goals16 could also focus political attention on 
multimorbidity.
Research into practice. 
Engagement with policymakers is essential if evidence is to inform practice. Conventional academic 
publication routes are not an ideal way to disseminate information to policymakers, who may have limited 
experience of fields of medicine and little time for in-depth analysis. Equally, researchers may not have the 
skills to prepare materials in ways that meet policymakers’ needs, and often receive no credit for engaging 
with policymakers or influencing practice. Specialist mediators can play an important role in translating 
academic outputs into formats that are suitable for policymakers
In most countries in the region, further work is needed to develop policymakers’ capacity to use research 
evidence and researchers’ capacity to generate policy-relevant outputs. Research is also needed on the 
most effective processes and systems to underpin evidence-based policymaking.
In practical terms, it may be helpful to engage with policymakers early in the development of research 
projects (see the PRIME project box) to ensure that research meets their needs and to encourage wider 
ownership of a project and its findings.
PRIME: Programme for Improving Mental Health Care
The PRIME programme is an international partnership that is developing, 
implementing, evaluating and scaling up district-level mental healthcare plans 
in five low- and middle-income countries (LMICs) – Ethiopia, India, Nepal, South 
Africa and Uganda.
There is an urgent need to integrate better mental healthcare into primary care to address 
huge treatment gaps in LMICs. The PRIME programme17 has been generating evidence on 
how best to do this, by developing integrated mental healthcare plans, evaluating them in 
five district sites, and using this learning to inform wider scaling up to 94 facilities.
The programme achieved a significant impact on the detection of mental health conditions, 
access to treatment, and clinical outcomes, although impacts varied markedly between 
countries. It demonstrated that mental healthcare plans can be integrated into primary care 
in low-resource settings, although substantial investment in training, supervision and health 
system strengthening is required.
www.mhinnovation.net/innovations/prime-programme-improving-mental-health-care
16. Hurst JR, Dickhaus J, Maulik PK, Miranda JJ, Pastakia SD, Soriano JB, Siddharthan T, Vedanthan R; GACD Multi-Morbidity Working Group (2018) 
 Global Alliance for Chronic Disease researchers’ statement on multimorbidity. Lancet Glob Health 6(12):e1270-e1271.
17. Lund C, et al. (2012) PRIME: A programme to reduce the treatment gap for mental disorders in five low- and middle-income countries. PLoS 
 Med 9: e1001359.
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Community engagement.
Some communities may have limited understanding of multimorbidity and may adopt a fatalistic approach 
to long-term conditions, for example believing them to be an inevitable consequence of ageing. Such 
misconceptions can be obstacles to the adoption of healthier lifestyles and to adherence to medication – 
conditions such as hypertension, for example, are often poorly controlled in LMICs. 
More attention could be given to multimorbidity health literacy – most information materials typically 
focus on single conditions. More social and behavioural research is needed to understand attitudes and 
behavioural motivations, to inform the design of preventive interventions. There is also the potential to 
involve communities in the co-creation of contextually tailored interventions for prevention or treatment, 
to ensure interventions are locally appropriate and to encourage community ownership.
African-PREDICT
The African-PREDICT programme is a newly launched cohort study characterising 
the development of hypertension in young black Africans.
Although hypertension is on the decline globally, it is increasing in Africa, with African 
countries having the world’s highest mean blood pressure levels. In South Africa, nearly four 
in five adults have hypertension. 
Black South Africans are at an increased risk of hypertension, potentially for several reasons 
– lower socioeconomic status, worse access to healthcare and/or pathophysiological 
factors. However, the relative contribution of these factors, and in particular the impact of 
pathophysiological factors, is poorly understood.
The African-PREDICT study18 is collecting a wide range of demographic and behavioural 
data, as well as biological samples, from around 1,200 people (black and white, men and 
women) aged 20–30 years. They will undergo fiveyear follow-up assessments to monitor 
the emergence of hypertension. The study should reveal more about the pathophysiology 
of early cardiovascular disease and how it differs between people of African and European 
ancestry. It will also identify key factors associated with the risk of its development, pointing 
the way to targeted preventive interventions.
http://health-sciences.nwu.ac.za/hart/current-projects
18. Schutte AE, Gona PN, Delles C, Uys AS, Burger A, Mels CM, Kruger R, Smith W, Fourie CM, Botha S, Lammertyn L, van Rooyen JM,   
 Gafane-Matemane LF, Mokwatsi GG, Breet Y, Kruger HS, Zyl TV, Pieters M, Zandberg L, Louw R, Moss SJ, Khumalo IP, Huisman HW (2019)  
 The African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension (African-PREDICT): Design,  
 recruitment and initial examination. Eur J Prev Cardiol 26(5):458-470.
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Sub-Saharan Africa is making significant progress in improving the health of its people. Great strides have 
been made in combatting infectious disease, enhancing access to antiretrovirals, and in improving maternal 
and child health. As a result, life expectancy has been improving markedly. 
However, the growing adoption of westernised lifestyles is driving a new NCD epidemic. With its high 
infectious disease burden, people living longer, and a growing population, the region will face a huge 
challenge from multimorbidity in the near future. 
Nevertheless, this may be an opportune moment to highlight the current and future challenges presented 
by multimorbidity. A global focus on primary healthcare and universal health coverage is encouraging 
national governments to consider the health needs of their populations and how health systems can be 
efficiently organised in patient-centric ways. Multimorbidity considerations should therefore be at the heart 
of initiatives to strengthen health systems. 
Multimorbidity research has a crucial role to play not just in providing a clearer picture of regional 
multimorbidity challenges, but also in identifying the most effective ways to prevent and manage it. The 
outline research priorities presented here could provide the first step towards defining a regional research 
agenda to address these emerging challenges.
Conclusion
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